MGIC Investment (MTG) Q3 2026 Earnings Call Transcript

MGIC reported third-quarter 2026 net income of $175 million, down from $191.1 million a year earlier, while diluted EPS rose to $0.85 from $0.83 and new insurance written increased 3.6% to $17.1 billion. Delinquencies reached 2.52%, up 20 basis points year over year, as management expects a gradual increase with greater exposure to newer loan vintages; fully developed ultimate loss rates on recent notices are moving toward 3%–4%, below the 7.5% initial assumption. MGIC repurchased $152.5 million of shares, paid a $0.17-per-share dividend and returned capital at 122% of trailing-four-quarter net income; it also expects 2026 operating expenses slightly below the prior $190 million–$200 million range.

Analysis

The key earnings-quality issue is that reserve releases are cushioning reported results while underlying credit normalizes. Favorable development is not a dependable run-rate: if cure experience merely returns toward management’s higher initial claim assumption, that support fades even without a recession. Track new-notice ultimate losses and reserve development separately from EPS; the 7.5% initial assumption versus recent 3%–4% developed outcomes leaves room for releases, but also creates revision risk if unemployment or home prices deteriorate.

Capital returns support per-share earnings and may put a floor under the stock when management sees value, but payouts above earnings are not a durable growth engine. Buybacks also shrink the investment portfolio, limiting the benefit from reinvesting above the existing book yield. Reinsurance helps preserve capital capacity, though forward coverage is not a substitute for underwriting discipline or proof of attractive economics across future vintages. These dynamics matter for competitors such as Radian and Essent as well as MGIC.

Over 1–3 months, watch delinquency acceleration, reserve development, and buyback pace; over 6–18 months, the larger risk is policy duration. A cancellation pilot using automated home values could shorten coverage on low-risk, appreciating loans, reducing premium persistence and leaving a less favorable risk mix. The market may overfocus on current benign losses and underprice this regulatory optionality; conversely, the pilot remains exploratory, so treating it as an imminent earnings shock is premature. No compelling directional trade without valuation and peer-spread context.

Key Decisions for Investors

• Do not extrapolate reserve releases into recurring earnings. Monitor quarterly new-notice claim development and delinquency trends; reassess if credit deterioration begins to outpace management’s normalization narrative or favorable development stops.
• Keep MTG on a watchlist rather than initiate a directional position solely on this call. Verify valuation versus book value and Radian/Essent before considering a relative-value trade; management’s buyback sensitivity is a potential support, not a guaranteed floor.
• Treat mortgage-insurance cancellation automation as a medium-term catalyst, not an immediate short. Track FHFA/GSE pilot design—especially valuation method, seasoning, and payment-history rules—and revisit if a proposal materially accelerates cancellation of performing policies.
• Stress-test capital returns against lower persistency, higher claims, and continued portfolio shrinkage. A materially faster delinquency rise, weaker reserve development, or reduced buyback activity would falsify the benign-credit/capital-return support case.